178. Dr. Matt Kaeberlein: The Science, Risk, and Hype Behind Today's Longevity Trends

0:00-1:14:07

If you care about longevity, you have probably seen the same pattern over and over again. A new peptide, supplement, biological age test, off-label drug, or protocol starts gaining attention, and suddenly it sounds like the missing piece everyone should be using. The hard part is not wanting to be proactive. The hard part is knowing which claims have real evidence behind them, which ones are still early signals, and which ones may carry risks no one is measuring carefully enough. In this episode, I sit down with Dr. Matt Kaeberlein to talk about how to think about longevity when the answer is rarely a simple yes or no. This conversation helps separate excitement from certainty, and shows why the real question is not only whether something might work, but whether the evidence, safety data, product quality, and risk-reward equation are strong enough to act on. Dr. Matt Kaeberlein is a scientist in the biology of aging and one of the most respected voices bringing scientific discipline to the longevity conversation. He has been involved with the Interventions Testing Program, which rigorously tests aging interventions in mice, and is one of the leaders behind the Dog Aging Project, a large-scale study looking at aging, health, and longevity in companion dogs. His work sits at the intersection of curiosity and caution, which makes him the right person to talk about what is promising, what is overhyped, and what still needs better evidence.

Publisher

Extend Podcast with Darshan Shah, MD

Link

03add746-5496-41d9-bcc9-511a526491e9.libsyn.com/178-dr-matt-kaeberlein-the-science-risk-and-hype-behind-todays-longevity-trends

Published

July 2, 2026

Duration

1h 14m

Format

Podcast

Category

Lifestyle · Health & Wellness

Source

RSS feed

Host

Darshan Shah, MD

EP

Extend Podcast with Darshan Shah, MD

@extendpodcastwithdar

#mattkaeberlein #science #todayslongevitytrends

The Nile